Luisa Carbognin

2.6k total citations · 1 hit paper
67 papers, 1.3k citations indexed

About

Luisa Carbognin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Luisa Carbognin has authored 67 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 28 papers in Pulmonary and Respiratory Medicine and 28 papers in Cancer Research. Recurrent topics in Luisa Carbognin's work include Breast Cancer Treatment Studies (19 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Genomics and Diagnostics (13 papers). Luisa Carbognin is often cited by papers focused on Breast Cancer Treatment Studies (19 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer Genomics and Diagnostics (13 papers). Luisa Carbognin collaborates with scholars based in Italy, Malaysia and Spain. Luisa Carbognin's co-authors include Emilio Bria, Giampaolo Tortora, Sara Pilotto, Isabella Sperduti, Matteo Brunelli, Aldo Scarpa, Michèle Milella, Diana Giannarelli, Ida Paris and Anna Caliò and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Luisa Carbognin

64 papers receiving 1.3k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers

2015 375 citations Luisa Carbognin, Sara Pilotto et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luisa Carbognin Italy	20	928	402	337	320	259	67	1.3k
Alexandros Xyrafas Switzerland	16	766 0.8×	314 0.8×	185 0.5×	267 0.8×	209 0.8×	38	1.1k
Deepak Kilari United States	18	558 0.6×	466 1.2×	300 0.9×	281 0.9×	126 0.5×	110	1.1k
Lorena Incorvaia Italy	24	910 1.0×	675 1.7×	602 1.8×	481 1.5×	247 1.0×	113	1.9k
Ramon Andrade de Mello Portugal	21	745 0.8×	565 1.4×	477 1.4×	314 1.0×	202 0.8×	89	1.4k
Yuka Asano Japan	23	1.0k 1.1×	289 0.7×	278 0.8×	470 1.5×	255 1.0×	111	1.6k
Bradley G. Somer United States	16	808 0.9×	304 0.8×	412 1.2×	279 0.9×	123 0.5×	45	1.3k
Antonio Febbraro Italy	18	649 0.7×	314 0.8×	249 0.7×	241 0.8×	110 0.4×	56	1.2k
Alexios Matikas Sweden	19	929 1.0×	370 0.9×	395 1.2×	413 1.3×	276 1.1×	92	1.4k
Tamami Morisaki Japan	20	619 0.7×	230 0.6×	472 1.4×	385 1.2×	177 0.7×	98	1.2k
Dale R. Shepard United States	17	478 0.5×	470 1.2×	419 1.2×	258 0.8×	107 0.4×	75	1.2k

Countries citing papers authored by Luisa Carbognin

Since Specialization

Citations

This map shows the geographic impact of Luisa Carbognin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luisa Carbognin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luisa Carbognin more than expected).

Fields of papers citing papers by Luisa Carbognin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luisa Carbognin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luisa Carbognin. The network helps show where Luisa Carbognin may publish in the future.

Co-authorship network of co-authors of Luisa Carbognin

This figure shows the co-authorship network connecting the top 25 collaborators of Luisa Carbognin. A scholar is included among the top collaborators of Luisa Carbognin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luisa Carbognin. Luisa Carbognin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Botticelli, Andrea, Alessandra Fabi, Alessandro Rossi, et al.. (2024). Trastuzumab deruxtecan in patients with breast cancer with brain metastases: The DE-REAL study.. Journal of Clinical Oncology. 42(16_suppl). 1032–1032. 1 indexed citations

Franco, Antonio, Alba Di Leone, Alessandra Fabi, et al.. (2023). Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting. Cancers. 15(9). 2450–2450.

Paolis, Elisa De, Ida Paris, Bruno Tilocca, et al.. (2023). Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine. Frontiers in Oncology. 12. 1053035–1053035. 4 indexed citations

Carbognin, Luisa, E. Di Monte, Gaetano Arcuri, et al.. (2023). 138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study. ESMO Open. 8(1). 101477–101477. 1 indexed citations

Sposito, Marco, Lorenzo Belluomini, Daniela Tregnago, et al.. (2023). Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories. Journal of Personalized Medicine. 13(10). 1427–1427. 2 indexed citations

Carbognin, Luisa, Alessandra Fabi, Diana Giannarelli, et al.. (2022). Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer. Current Oncology. 29(10). 7218–7228. 4 indexed citations

Paris, Ida, Luisa Carbognin, Simona Duranti, et al.. (2022). PI3K Inhibitors in Advanced Breast Cancer: The Past, The Present, New Challenges and Future Perspectives. Cancers. 14(9). 2161–2161. 27 indexed citations

Rossi, Antônio, Sara Pilotto, Luisa Carbognin, et al.. (2021). Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer. SHILAP Revista de lepidopterología. 2(3). 207–222. 2 indexed citations

Duranti, Simona, Alessandra Fabi, Marco Filetti, et al.. (2021). Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials. Cancers. 13(20). 5198–5198. 10 indexed citations

10.

Falcone, Italia, Fabiana Conciatori, Chiara Bazzichetto, et al.. (2020). AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations. International Journal of Molecular Sciences. 21(22). 8419–8419. 20 indexed citations

11.

Carbognin, Luisa, Ilaria Trestini, Isabella Sperduti, et al.. (2020). 179P Prognostic impact of body composition (BC) changes during neoadjuvant chemotherapy (NACT) in breast cancer patients (pts). Annals of Oncology. 31. S314–S314. 1 indexed citations

12.

Paris, Ida, Luisa Carbognin, Giacomo Corrado, et al.. (2020). Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach. Clinical Breast Cancer. 21(1). e120–e127. 22 indexed citations

13.

Trestini, Ilaria, Αναστάσιος Γκουντάκος, Luisa Carbognin, et al.. (2019). Muscle derangement and alteration of the nutritional machinery in NSCLC. Critical Reviews in Oncology/Hematology. 141. 43–53. 14 indexed citations

14.

Piro, Geny, Carmine Carbone, Luisa Carbognin, et al.. (2019). Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story. Cancers. 11(10). 1525–1525. 30 indexed citations

15.

Trestini, Ilaria, Luisa Carbognin, Clelia Bonaiuto, Giampaolo Tortora, & Emilio Bria. (2018). The obesity paradox in cancer: clinical insights and perspectives. Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity. 23(2). 185–193. 49 indexed citations

16.

Carbognin, Luisa, Isabella Sperduti, Grazia Arpino, et al.. (2017). A propensity score analysis exploring the impact of adjuvant chemotherapy (aCT) in 739 patients (pts) affected by early stage pure Invasive Lobular breast Carcinoma (ILC). Annals of Oncology. 28. vi27–vi27. 1 indexed citations

17.

Carbognin, Luisa, Isabella Sperduti, Mariangela Ciccarese, et al.. (2016). Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival. The Breast. 29. 24–30. 9 indexed citations

18.

Carbognin, Luisa, Isabella Sperduti, Rolando Nortilli, et al.. (2015). Balancing activity and tolerability of neoadjuvant paclitaxel- and docetaxel-based chemotherapy for HER2-positive early stage breast cancer: Sensitivity analysis of randomized trials. Cancer Treatment Reviews. 41(3). 262–270. 15 indexed citations

19.

Carbognin, Luisa, Sara Pilotto, Michèle Milella, et al.. (2015). Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers. PLoS ONE. 10(6). e0130142–e0130142. 375 indexed citations breakdown →

20.

Bria, Emilio, Luisa Carbognin, Jenny Furlanetto, et al.. (2014). Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials. Cancer Treatment Reviews. 40(7). 847–856. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact